However, studies by ourselves and others have demonstrated that the reduction in BP induced by SGLT2 inhibitors persists throughout an entire day, but with a greater reduction in BP during the daytime than during the nighttime in T2DM patients23,49,50. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.